Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease

References

• Kullo IJ, Solomon CG, Rooke TW. Peripheral artery disease. N Engl J Med. 2016;374(9):861–871. doi:10.1056/NEJMcp1507631
   PubMedGoogle Scholar
• Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135(12):e726–e779. doi:10.1161/CIR.0000000000000471
   PubMed Web of Science ®Google Scholar
• Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi:10.1016/S0140-6736(13)61249-0
   PubMed Web of Science ®Google Scholar
• Hamburg NM, Creager MA. Pathophysiology of intermittent claudication in peripheral artery disease. Circ J. 2017;81(3):281–289. doi:10.1253/circj.CJ-16-1286
   PubMed Web of Science ®Google Scholar
• Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020–e1030. doi:10.1016/S2214-109X(19)30255-4
   PubMed Web of Science ®Google Scholar
• Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–1602.
   PubMed Web of Science ®Google Scholar
• Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–1544.
   PubMed Web of Science ®Google Scholar
• Brostow DP, Hirsch AT, Collins TC, Kurzer MS. The role of nutrition and body composition in peripheral arterial disease. Nat Rev Cardiol. 2012;9(11):634–643. doi:10.1038/nrcardio.2012.117
   PubMed Web of Science ®Google Scholar
• McCully KS. Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol. 2015;8(2):211–219. doi:10.1586/17512433.2015.1010516
   PubMed Web of Science ®Google Scholar
• Malinow MR. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin Chem. 1995;41(1):173–176. doi:10.1093/clinchem/41.1.173
   PubMedGoogle Scholar
• McCully KS. Homocysteine metabolism, atherosclerosis, and diseases of aging. Compr Physiol. 2015;6(1):471–505.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481–2485. doi:10.1001/jama.285.19.2481
   PubMed Web of Science ®Google Scholar
• Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation. 2006;113(22):2623–2629. doi:10.1161/CIRCULATIONAHA.105.608679
   PubMed Web of Science ®Google Scholar
• Taylor LM, DeFrang RD, Harris EJ, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg. 1991;13(1):128–136. doi:10.1016/0741-5214(91)90020-U
   PubMedGoogle Scholar
• Bertoia ML, Pai JK, Cooke JP, et al. Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. Atherosclerosis. 2014;235(1):94–101. doi:10.1016/j.atherosclerosis.2014.04.010
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM. Symptomatic peripheral arterial disease in women. Circulation. 2008;117(6):823–831. doi:10.1161/CIRCULATIONAHA.107.719369
   PubMedGoogle Scholar
• Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995;274(13):1049–1057. doi:10.1001/jama.1995.03530130055028
   PubMed Web of Science ®Google Scholar
• Khandanpour N, Loke YK, Meyer FJ, Jennings B, Armon MP. Homocysteine and peripheral arterial disease: systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2009;38(3):316–322. doi:10.1016/j.ejvs.2009.05.007
   PubMed Web of Science ®Google Scholar
• Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg. 1997;11(3):217–223. doi:10.1007/s100169900037
   PubMedGoogle Scholar
• Rong D, Liu J, Jia X, et al. Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population. Atherosclerosis. 2017;263:205–210. doi:10.1016/j.atherosclerosis.2017.05.006
   PubMed Web of Science ®Google Scholar
• Fan F, Qi L, Jia J, et al. Noninvasive central systolic blood pressure is more strongly related to kidney function decline than peripheral systolic blood pressure in a Chinese community-based population. Hypertension. 2016;67(6):1166–1172. doi:10.1161/HYPERTENSIONAHA.115.07019
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Qin X, et al. Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45–75 years. Br J Nutr. 2012;109(7):1284–1293. doi:10.1017/S0007114512003157
   PubMedGoogle Scholar
• Qin X, Huo Y. H-Type hypertension, stroke and diabetes in China: opportunities for primary prevention. J Diabetes. 2016;8(1):38–40. doi:10.1111/1753-0407.12333
   PubMed Web of Science ®Google Scholar
• Stanger O, Herrmann W, Pietrzik K, et al. DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med. 2003;41(11):1392–1403. doi:10.1515/CCLM.2003.214
   PubMedGoogle Scholar
• McCully KS. Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr. 2007;86(5):1563S–1568S. doi:10.1093/ajcn/86.5.1563S
   PubMed Web of Science ®Google Scholar
• Momin M, Fan F, Li J, et al. Associations of plasma homocysteine levels with peripheral systolic blood pressure and noninvasive central systolic blood pressure in a community-based Chinese population. Sci Rep. 2017;7(1):6316. doi:10.1038/s41598-017-06611-3
   PubMedGoogle Scholar
• Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313(13):1325–1335. doi:10.1001/jama.2015.2274
   PubMed Web of Science ®Google Scholar
• Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham offspring cohort. Am J Clin Nutr. 2001;73(3):613–621. doi:10.1093/ajcn/73.3.613
   PubMed Web of Science ®Google Scholar
• Akanji AO, Thalib L, Al-Isa AN. Folate, vitamin B12 and total homocysteine levels in Arab adolescent subjects: reference ranges and potential determinants. Nutr Metab Cardiovasc Dis. 2012;22(10):900–906. doi:10.1016/j.numecd.2010.10.020
   PubMedGoogle Scholar
• Xu X, Li J, Sheng W, Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis. 2008;26(1):48–62. doi:10.1159/000135653
   PubMedGoogle Scholar
• Kang SS, Wong PW, Bock HG, Horwitz A, Grix A. Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet. 1991;48(3):546–551.
   PubMedGoogle Scholar
• Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–113. doi:10.1038/ng0595-111
   PubMed Web of Science ®Google Scholar
• Zaric BL, Obradovic M, Bajic V, Haidara MA, Jovanovic M, Isenovic ER. Homocysteine and hyperhomocysteinaemia. Curr Med Chem. 2019;26(16):2948–2961. doi:10.2174/0929867325666180313105949
   PubMed Web of Science ®Google Scholar
• Sun Y, Chien K-L, Hsu H-C, Su T-C, Chen M-F, Lee Y-T. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study. Circ J. 2009;73(8):1423–1430. doi:10.1253/circj.CJ-08-1077
   PubMed Web of Science ®Google Scholar
• Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci. 2010;298(1–2):153–157. doi:10.1016/j.jns.2010.07.013
   PubMed Web of Science ®Google Scholar
• Al-Delaimy WK, Merchant AT, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med. 2004;116(4):236–240. doi:10.1016/j.amjmed.2003.09.038
   PubMed Web of Science ®Google Scholar
• Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816. doi:10.1093/eurheartj/ehx095
   PubMed Web of Science ®Google Scholar
• Eraso LH, Fukaya E, Mohler ER 3rd, Xie D, Sha D, Berger JS. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol. 2014;21(6):704–711. doi:10.1177/2047487312452968
   PubMed Web of Science ®Google Scholar
• Subramaniam T, Nang EEK, Su Chi L, et al. Distribution of ankle—brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population. Vasc Med. 2011;16(2):87–95. doi:10.1177/1358863X11400781
   PubMed Web of Science ®Google Scholar
• Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67. doi:10.1016/j.jvs.2006.12.037
   PubMed Web of Science ®Google Scholar
• Patel T, Baydoun H, Patel NK, et al. Peripheral arterial disease in women: the gender effect. Cardiovasc Revasc Med. 2020;21(3):404–408. doi:10.1016/j.carrev.2019.05.026
   PubMed Web of Science ®Google Scholar
• Joosten MM, Pai JK, Bertoia ML, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012;308(16):1660-1667. doi:10.1001/jama.2012.13415
   PubMedGoogle Scholar